Myristyl bromide → HCID 178443151, 화합물
반응식
[CH2:1]([C:3]1[CH:8]=[CH:7][C:6]([N:9]2[CH:13]=[CH:12][N:11]=[CH:10]2)=[C:5]([C:14]([OH:16])=[O:15])[CH:4]=1)[CH3:2].[Br:17][CH2:18][CH2:19][CH2:20][CH2:21][CH2:22][CH2:23][CH2:24][CH2:25][CH2:26][CH2:27][CH2:28][CH2:29][CH2:30][CH3:31]>C1COCC1>[Br-:17].[CH2:1]([C:3]1[CH:8]=[CH:7][C:6]([N+:9]2[CH:13]=[CH:12][N:11]([CH2:31][CH2:30][CH2:29][CH2:28][CH2:27][CH2:26][CH2:25][CH2:24][CH2:23][CH2:22][CH2:21][CH2:20][CH2:19][CH3:18])[CH:10]=2)=[C:5]([C:14]([OH:16])=[O:15])[CH:4]=1)[CH3:2]참가 물질
4
실험 절차
According to the general synthesis procedure, 4.60 mmol (1.00 g) 1-(4-ethylcarboxyphenyl)imidazole and 5.50 mmol (1.50 g, 1.5 ml) 1-bromotetradecane are dissolved in 5 ml THF and heated for 68 h to 90° C.
후처리
- temperatureheated for 68 h to 90° C.